Michael Abern

Michael Abern

University of Illinois at Chicago

H-index: 28

North America-United States

About Michael Abern

Michael Abern, With an exceptional h-index of 28 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Illinois at Chicago, specializes in the field of Urologic oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial.

National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Letter.

Development and validation of a prostate biopsy risk calculator in Black men

Prostate‐derived circulating microRNAs add prognostic value to prostate cancer risk calculators

Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial

Biparametric Quantitative MRI for Prostate Cancer Detection

Advanced chronic kidney disease; a comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma

Michael Abern Information

University

Position

___

Citations(all)

2819

Citations(since 2020)

1910

Cited By

1501

hIndex(all)

28

hIndex(since 2020)

19

i10Index(all)

58

i10Index(since 2020)

44

Email

University Profile Page

University of Illinois at Chicago

Google Scholar

View Google Scholar Profile

Michael Abern Skills & Research Interests

Urologic oncology

Top articles of Michael Abern

Title

Journal

Author(s)

Publication Date

Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.

Sari Motlagh

Alireza Ghoreifi

Takafumi Yanagisawa

Tatsushi Kawada

Sascha Ahyai

...

2024/4/24

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial.

Hari Thambiah Vigneswaran

Martin Eklund

Andrea Discacciati

Tobias Nordström

Rebecca A Hubbard

...

2024/2/1

National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Letter.

Journal of Urology

Rand N Wilcox Vanden Berg

Michael Abern

2023/3/1

Development and validation of a prostate biopsy risk calculator in Black men

Journal of Urology

Neil A Mistry

Zequn Sun

Jamila Sweis

Cordero McCall

Norma Marshall

...

2023/11/1

Prostate‐derived circulating microRNAs add prognostic value to prostate cancer risk calculators

Journal of Extracellular Biology

Morgan L Zenner

Brenna Kirkpatrick

Trevor R Leonardo

Michael J Schlicht

Alejandra Cavazos Saldana

...

2023/11

Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial

Cancer medicine

Samuel Carbunaru

Zequn Sun

Cordero McCall

Bernice Ofori

Norma Marshall

...

2023/10

Biparametric Quantitative MRI for Prostate Cancer Detection

Topics in Magnetic Resonance Imaging

Meltem Uyanik

Hari T Vigneswaran

Graham R Hale

Peter Gann

Richard Magin

...

2023/12/1

Advanced chronic kidney disease; a comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

John V Dudinec

David I Ortiz-Melo

Michael E Lipkin

Michael R Abern

Ankeet M Shah

...

2023/6/1

The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A review

Rand N Wilcox Vanden Berg

Thomas Zilli

Vérane Achard

Tanya Dorff

Michael Abern

2023/12

Robotic single-port multiquadrant surgery to treat renal tumors and benign abdominal conditions.

Minerva Surgery

Antonio Cubisino

Nicolas H Dreifuss

Michael R Abern

Carolina Baz

Francesco M Bianco

2023/3/21

Perioperative outcomes in male patients undergoing cystectomy, radical colorectal procedure or total pelvic exenteration

Translational Andrology and Urology

Ushasi Naha

Artyom Khurshudyan

Hari T Vigneswaran

Mahmoud Mima

Michael R Abern

...

2023/11/11

MP33-16 BIPARAMETRIC QUANTITATIVE MRI FOR PROSTATE CANCER DETECTION

The Journal of Urology

Hari Vigneswaran

Meltem Uyanik

Karen Xie

Michael Abern

Manuel Duarte Ortigueira

...

2022/5

NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines

Journal of the National Comprehensive Cancer Network

Thomas W Flaig

Philippe E Spiess

Michael Abern

Neeraj Agarwal

Rick Bangs

...

2022/8/1

Investigating the heterogeneity of viscoelastic properties in prostate cancer using MR elastography at 9.4 T in fresh prostatectomy specimens

Magnetic Resonance Imaging

Rolf Reiter

Shreyan Majumdar

Steven Kearney

Andre Kajdacsy-Balla

Virgilia Macias

...

2022/4/1

Prostate cancer disparities in Hispanics using the national cancer database

Urology

Matthew Del Pino

Michael R Abern

Daniel M Moreira

2022/7/1

Retroperitoneal dermoid cyst presenting with radiculopathy symptoms: a case report

Journal of surgical case reports

Margot Kelly-Hedrick

Jason M Frerich

Emily M Peairs

Diana M Cardona

Rohith Arcot

...

2022/12

Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis

Hari T Vigneswaran

Luke Mittelstaedt

Alessio Crippa

Martin Eklund

Adriana Vidal

...

2022/6

Comparison of perioperative outcomes between retroperitoneal single-port and multiport robot-assisted partial nephrectomies

Journal of Endourology

Arnold R Palacios

Luca Morgantini

Ryan Trippel

Simone Crivellaro

Michael R Abern

2022/12/1

Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For

European urology focus

Simpa S Salami

2022/5

Reconciling discordance between prostate biopsy histology and magnetic resonance imaging suspicion–implementation of a quality improvement protocol of imaging re-review and …

Srinath Kotamarti

Rajan T Gupta

Bangchen Wang

Denis Séguier

Zoe Michael

...

2022/10/1

See List of Professors in Michael Abern University(University of Illinois at Chicago)